Equity-Based Compensation | 12. EQUITY-BASED COMPENSATION Stock Option Award Activity For three months ended March 31, 2023 and 2022 , $ 0 and $ 62 , respectively, of equity-based compensation expense was recognized related to equity options granted. The following table summarizes stock option activity for the three months ended March 31, 2023: Stock Options Weighted-Average Exercise Price Outstanding as of December 31, 2022 6,915,715 $ 0.61 Exercised ( 80,520 ) 0.70 Forfeited ( 18,563 ) 0.74 Outstanding as of March 31, 2023 6,816,632 $ 0.60 Exercisable as of March 31, 2023 6,785,368 $ 0.60 Restricted Stock Units ( “ RSUs”) The vesting conditions for the RSUs are a mix of time-based and performance-based vesting conditions. The RSUs with performance-based vesting conditions are based on achievement of revenue or certain annual Adjusted Earnings Before Interest, Income Tax, Depreciation and Amortization (“Adjusted EBITDA”) targets . No compensation expense was recognized on the RSUs with performance-based vesting conditions (“ PSUs”) for the three months ended March 31, 2023 as there were no unvested PSUs outstanding in the period. No compensation expense was recognized on PSUs for the three months ended March 31, 2022 on the basis that achievement of the specified performance targets was not considered probable to be met in the period and all outstanding PSUs were ultimately cancelled as of December 31, 2022. For three months ended March 31, 2023 and 2022 , $ 1,443 , and $ 1,926 of equity-based compensation expense was recognized related to RSUs. The following summarizes RSU activity for the three months ended March 31, 2023: Restricted Stock Units Weighted-Average Grant Date Fair Value Outstanding as of December 31, 2022 2,764,681 $ 9.23 Granted — — Vested ( 852,303 ) 9.26 Forfeited ( 73,573 ) 9.52 Outstanding as of March 31, 2023 1,838,805 $ 9.21 Employee Stock Purchase Plan On December 21, 2021, the Company’s stockholders approved the AdTheorent Holding Company, Inc. Employee Stock Purchase Plan (the “ESPP”) and the ESPP became effective on such date with an authorized 2,026,328 shares of common stock (subject to certain adjustments to reflect changes in the Company’s capitalization) are reserved and may be purchased by eligible employees who become participants in the ESPP. The purchase price per share of the common stock is the lesser of 85 % of the fair market value of a share of common stock on the offering date or 85 % of the fair market value of a share of common stock on the purchase date. The first offering period under the ESPP began August 15, 2022 and ended January 14, 2023. Beginning with the second offering period beginning January 14, 2023, each offering period will be six months. Pursuant to the ESPP, on January 1, 2023, the Company added 869,863 shares available for issuance. As of March 31, 2023, there wer e 2,784,758 shares of common stock available for issuance pursuant to the ESPP. Total compensation expense related to the ESPP was $ 37 and $ 0 for the three months ended March 31, 2023 and 2022, respectively, classified within each applicable operating expense category on the accompanying Consolidated Statements of Operations and in the equity-based compensation table below. The fair value of the purchase rights granted under the ESPP for the offering period beginning January 14, 2023 was $ 0.68 . It was estimated by applying the Black-Scholes option-pricing model to the purchase period in the offering period using the following assumptions: January 14, 2023 Grant price $ 1.85 Expected term 6 months Expected volatility 76.91 % Risk-free interest rate 4.77 % Expected dividend yield 0.00 % Grant price - Closing stock price on the first day of the offering period Expected Term - The expected term is based on the end date of the purchase period of each offering period, which is three months from the commencement of each new offering period. Expected volatility - The expected volatility is based on historical volatility of the Company’s stock as well as the implied volatility from publicly traded options on the Company’s stock. Risk-free interest rate - The risk-free interest rate is based on a U.S. Treasury rate in effect on the date of grant with a term equal to the expected term. Equity-Based Compensation Expense The following table summarizes the total equity-based compensation expense included in the Condensed Consolidated Statements of Operations: Three Months Ended March 31, 2023 2022 Platform operations $ 207 $ 262 Sales and marketing 615 578 Technology and development 183 382 General and administrative 475 766 Total equity-based compensation expense $ 1,480 $ 1,988 As of March 31, 2023 and 2022, equity -based compensation included in capitalized software development costs was $ 72 and $ 0 , respectively. As of March 31, 2023, there was $ 3 of total unrecognized compensation cost related to non-vested stock options, which is expected to be recognized over a weighted average period of 0.2 years. As of March 31, 2023, there was $ 14,141 of total unrecognized compensation expense related to the RSUs, which is expected to be recognized over a weighted average period of 2.4 years. |